연구성과로 돌아가기
2025 연구자 정보 (484 / 657)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Hwang, Sang Mee (Hwang, SM) |
Seoul Natl Univ, Seoul Natl Univ Bundang Hosp, Dept Lab Med, Coll Med, Seongnam, South Korea Seoul Natl Univ, Bundang Hosp, Dept Lab Med, Coll Med, Seongnam, South Korea |
JUU-9780-2023 Hwang, Sang Mee |
|
[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions [JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions (vol 60, 9, 2025) |
ESCI | 36.2 | HEMATOLOGY | kihyunkimk@gmail.com; | ||
|
Jo, Jae-Cheol (Jo, JC) |
Univ Ulsan, Coll Med, Dept Hematol & Oncol, Ulsan Univ Hosp, Ulsan, South Korea |
CAE-9453-2022 Jo, Jae-Cheol |
|
[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions [JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions (vol 60, 9, 2025) |
ESCI | 36.2 | HEMATOLOGY | kihyunkimk@gmail.com; | ||
|
Jung, Sung-Hoon (Jung, SH) |
제1저자 | Chonnam Natl Univ, Chonnam Natl Univ Hwasun Hosp, Dept Hematol Oncol, Med Sch, Hwasun, South Korea |
|
|
[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions [JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions (vol 60, 9, 2025) |
ESCI | 36.2 | HEMATOLOGY | kihyunkimk@gmail.com; | |
|
Kang, Ka-Won (Kang, KW) |
Korea Univ, Coll Med, Dept Internal Med, Div Hematol Oncol, Seoul, South Korea |
HKW-8137-2023 Kang, Ka-Won |
0000-0003-1462-0502 Kang, Ka-Won |
[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions [JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions (vol 60, 9, 2025) |
ESCI | 36.2 | HEMATOLOGY | kihyunkimk@gmail.com; | ||
|
Kim, Dae Sik (Kim, DS) |
Korea Univ, Guro Hosp, Div Hematol Oncol, Guro Hosp, Seoul 136701, South Korea Korea Univ, Dept Internal Med, Div Oncol & Hematol, Guro Hosp, Seoul, South Korea |
HTT-1263-2023 Kim, Dae Sik |
|
[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions [JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions (vol 60, 9, 2025) |
ESCI | 36.2 | HEMATOLOGY | kihyunkimk@gmail.com; | ||
|
Kim, Jin Seok (Kim, JS) |
Yonsei Univ, Coll Med, Dept Internal Med, Div Hematol,Severance Hosp, Seoul, South Korea Yonsei Univ, Severance Hosp, Dept Internal Med, Div Hematol,Coll Med, Seoul, South Korea |
|
|
[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions [JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions (vol 60, 9, 2025) |
ESCI | 36.2 | HEMATOLOGY | kihyunkimk@gmail.com; | ||
|
Kim, Kyoung Ha (Kim, KH) |
Soonchunhyang Univ, Dept Internal Med, Div Hematol & Oncol, Seoul Hosp, Seoul, South Korea |
|
|
[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions [JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions (vol 60, 9, 2025) |
ESCI | 36.2 | HEMATOLOGY | kihyunkimk@gmail.com; | ||
|
Kim, Sung Yong (Kim, SY) |
Konkuk Univ, Konkuk Univ Med Ctr, Sch Med, Sch Med, Seoul, South Korea Konkuk Univ, Sch Med, Hematol & Oncol, Med Ctr, Seoul, South Korea |
|
|
[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions [JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions (vol 60, 9, 2025) |
ESCI | 36.2 | HEMATOLOGY | kihyunkimk@gmail.com; | ||
|
Kim, Sung-Hyun (Kim, SH) |
Dong A Univ, Coll Med, Dept Internal Med, Div Hematol Oncol, Busan, South Korea Korea Polytech Coll, Dept Biomed Anal, Chungnam, South Korea |
|
|
[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions [JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions (vol 60, 9, 2025) [JCR상위 12.0] Flavonoid gossypetin protects alveolar bone and limits inflammation in ligature-induced periodontitis in mice |
ESCI SCIE |
12.0 |
HEMATOLOGY DENTISTRY, ORAL SURGERY & MEDICINE |
kihyunkimk@gmail.com; ylee@knu.ac.kr; |
||
|
Kim, Yu Ri (Kim, YR) |
Yonsei Univ, Coll Med, Dept Internal Med, Div Hematol,Severance Hosp, Seoul, South Korea Yonsei Univ, Severance Hosp, Dept Internal Med, Div Hematol,Coll Med, Seoul, South Korea |
|
|
[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions [JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions (vol 60, 9, 2025) |
ESCI | 36.2 | HEMATOLOGY | kihyunkimk@gmail.com; | ||
|
Kwon, Jihyun (Kwon, J) |
Chungbuk Natl Univ, Coll Med, Dept Internal Med Hematol & Oncol, Cheongju 361763, Chungbuk, South Korea Chungbuk Natl Univ, Coll Med, Dept Internal Med Hematol & Oncol, Cheongju, South Korea |
|
|
[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions [JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions (vol 60, 9, 2025) |
ESCI | 36.2 | HEMATOLOGY | kihyunkimk@gmail.com; | ||
|
Lee, Ho Sup (Lee, HS) |
Kosin Univ, Coll Med, Gospel Hosp, Coll Med, Busan, South Korea Kosin Univ, Coll Med, Gospel Hosp, Dept Internal Med, Busan, South Korea |
|
|
[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions [JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions (vol 60, 9, 2025) |
ESCI | 36.2 | HEMATOLOGY | kihyunkimk@gmail.com; | ||
|
Lee, Je-Jung (Lee, JJ) |
Chonnam Natl Univ, Chonnam Natl Univ Hwasun Hosp, Dept Hematol Oncol, Med Sch, Hwasun, South Korea Chonnam Natl Univ, Hwasun Hosp, Dept Hematol Oncol, Med Sch, Hwasun, South Korea |
|
|
[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions [JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions (vol 60, 9, 2025) |
ESCI | 36.2 | HEMATOLOGY | kihyunkimk@gmail.com; | ||
|
Lee, Ji Yun (Lee, JY) |
Seoul Natl Univ, Seoul Natl Univ Bundang Hosp, Dept Internal Med, Div Hematol & Med Oncol,Coll Med, Seongnam, South Korea Seoul Natl Univ, Coll Med, Dept Internal Med, Div Hematol & Med Oncol,Bundang Hosp, Seongnam, South Korea |
|
|
[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions [JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions (vol 60, 9, 2025) |
ESCI | 36.2 | HEMATOLOGY | kihyunkimk@gmail.com; | ||
|
Lee, Myung-won (Lee, MW) |
Chungnam Natl Univ Hosp, Dept Internal Med, Div Hematol & Oncol, Daejeon, South Korea |
|
|
[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions [JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions (vol 60, 9, 2025) |
ESCI | 36.2 | HEMATOLOGY | kihyunkimk@gmail.com; |
페이지 이동: